A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction
Completed · Phase 2 · Has a placebo group
Conditions studied: Dental Pain
In brief
This is a Phase 2 study designed to test the ability of investigational study drug ARRY-371797 to reduce pain in a postoperative pain model (third molar extraction), and to further evaluate the drug's safety. Approximately 250 subjects from the US will be enrolled in this study.
Key facts
- Study ID
- NCT00663767
- Run by
- Pfizer
- People needed
- 250
- Starts
- 2008-04-07
- Expected to finish
- 2008-06-20
- Last updated by the study team
- 2021-02-09
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- PPD Phase I Clinic — Austin, Texas, United States
- Lifetree Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.